Product
CRN04894
Aliases
CRN04894 Oral Solution
3 clinical trials
5 indications
Indication
Cushing's syndromeIndication
Cushing diseaseIndication
Ectopic ACTH SyndromeIndication
Congenital Adrenal HyperplasiaIndication
Healthy Control ParticipantsClinical trial
A Phase 1b/2a Open-label Multiple-ascending Dose Exploratory Study of CRN04894 in ACTH-dependent Cushing's Syndrome (Cushing's Disease or Ectopic ACTH Syndrome)Status: Recruiting, Estimated PCD: 2026-10-01
Clinical trial
A 12-week, Phase 2 Open-label, Sequential Dose Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 Treatment in Participants With Congenital Adrenal Hyperplasia (TouCAHn)Status: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Double-blind, Randomized, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CRN04894 in Healthy VolunteersStatus: Completed, Estimated PCD: 2022-04-11